CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance at Mar. 31, 2022	$ 1,542	$ 147,460,747	$ (130,329,181)		$ (141,708)	$ 16,991,400
Beginning balance, shares at Mar. 31, 2022	1,541,917
Issuance of common stock for cash under at the market program	$ 58	619,384				619,442
Issuances of common stock for cash under at the market program, shares	57,456
Stock-based compensation expense		215,437				215,437
Net Loss			(2,905,668)		(413)	(2,906,081)
Ending balance at Jun. 30, 2022	$ 1,600	148,295,568	(133,234,849)		(142,121)	14,920,198
Ending balance, shares at Jun. 30, 2022	1,599,373
Issuance of common stock for cash under at the market program	$ 691	8,307,078				8,307,078
Issuances of common stock for cash under at the market program, shares	690,628
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 5	(7,978)				(7,973)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares	4,624
Stock-based compensation expense		313,539				313,539
Net Loss			(3,807,430)			(3,807,430)
Other Comprehensive Loss
Ending balance at Sep. 30, 2022	$ 2,296	156,908,207	(137,042,279)		(142,121)	19,868,224
Ending balance, shares at Sep. 30, 2022	2,294,625
Beginning balance at Mar. 31, 2023	$ 2,299	157,426,606	(142,358,555)	(6,141)		15,064,209
Beginning balance, shares at Mar. 31, 2023	2,299,259
Issuance of common stock for cash under at the market program	$ 178	1,085,941				1,086,119
Issuances of common stock for cash under at the market program, shares	177,891
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 7	(8,379)				(8,372)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares	6,397
Stock-based compensation expense		250,114				250,114
Net Loss			(3,282,179)			(3,282,179)
Other Comprehensive Loss				(994)		(994)
Ending balance at Jun. 30, 2023	$ 2,484	158,754,282	(145,640,734)	(7,135)		13,108,897
Ending balance, shares at Jun. 30, 2023	2,483,547
Beginning balance at Mar. 31, 2023	$ 2,299	157,426,606	(142,358,555)	(6,141)		15,064,209
Beginning balance, shares at Mar. 31, 2023	2,299,259
Ending balance at Sep. 30, 2023	$ 2,493	159,001,611	(148,675,190)	(9,570)		10,319,344
Ending balance, shares at Sep. 30, 2023	2,492,908
Beginning balance at Jun. 30, 2023	$ 2,484	158,754,282	(145,640,734)	(7,135)		13,108,897
Beginning balance, shares at Jun. 30, 2023	2,483,547
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 9	(9,852)				(9,843)
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares	9,329
Stock-based compensation expense		257,181				257,181
Rounding for reverse split
Rounding for reverse split, shares	32
Net Loss			(3,034,456)			(3,034,456)
Other Comprehensive Loss				(2,435)		(2,435)
Ending balance at Sep. 30, 2023	$ 2,493	$ 159,001,611	$ (148,675,190)	$ (9,570)		$ 10,319,344
Ending balance, shares at Sep. 30, 2023	2,492,908